Medical equipment-maker Opto Circuits’ subsidiary Cardic Science Corporation has received US Food and Drug Administration (FDA) clearance for the sale of MySence heart, a revolutionary wearable Holter cardiac monitor.
The device is small, lightweight and disposable, enabling patients to wear it for an extended time. Its ECG signal quality is superior, facilitating early diagnosis of potentially life threatening heart diseases. It is also designed to be ultralow cost, permitting a much broader use of the Holter in the US and especially emerging markets.
Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.